LINCOLN.NS · Lincoln Pharmaceuticals Limited
India · RS rating 39 · As of 2026-10-14
| Price | 542.90 INR |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 10 / 37 / 68 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 39 / 27 / 68 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +211.4% |
| Sales growth Q/Q | -5.3% |
| Distance from 52-week high | +28.4% |
| Market cap (USD) | $117.5M |